NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.810
-0.370 (-7.14%)
At close: Jun 17, 2026, 4:00 PM EDT
4.750
-0.060 (-1.25%)
After-hours: Jun 17, 2026, 6:11 PM EDT
NTHI Revenue
In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.
Revenue (ttm)
$39.99K
Revenue Growth
-51.82%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
121.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNTHI News
- 16 hours ago - NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 - GlobeNewsWire
- 1 day ago - Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND - GlobeNewsWire
- 1 day ago - NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development - GlobeNewsWire
- 2 days ago - NeOnc Technologies files to sell 555,554 shares of common stock for holders - TheFly
- 2 days ago - WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates - Newsfile Corp
- 8 days ago - The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade - Newsfile Corp
- 19 days ago - The Next Great AI Revolution May Be Drug Delivery - GlobeNewsWire
- 4 weeks ago - NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones - GlobeNewsWire